Coronavirus Global Response Yesterday (June 27th,2020) ‘Global Goal: Unite for our Future’ Summit brought an additional €6.15 billion of funding under the Coronavirus Global Response, bringing the total pledged under the initiative since 4 May to almost €16 billion. ‘Team Europe’ contributed significantly to the success of the pledging summit – the European Commission, EU […]
… and $5.4 Billion In Loans and Guarantees—For A Total Of $6.9 Billion Pledged—To Combat the Disproportionate Impact of Covid-19 On Vulnerable and Disadvantaged Communities Summary International advocacy organization Global Citizen and the European Commission (EC) today hosted Global Goal: Unite for Our Future – The Summit and The Concert, as part of a global […]
The ‘Global Goal: Unite for our Future’pledging summit organised today by the European Commission and Global Citizen mobilised €6.15 billion in additional funding to help develop and ensure equitable access to coronavirus vaccines, tests and treatments. The money raised will also support economic recovery in the world’s most fragile regions and communities. This amount includes […]
President Ursula von der Leyen announced a new pledge of €4.9 billion by Team Europe, with the European Investment Bank, for universal access to coronavirus vaccines, tests and treatments. Read the transcript of her first statements during the ‘Global Goal: Unite for our Future’ Summit. The event is ongoing and can be watched here. On […]
The European Commission has approved four Italian aid schemes to support companies and self-employed workers affected by the coronavirus outbreak. The four measures, which are part of a wider Italian support package included in the so-called “Decreto Rilancio”,were approved under the State aid Temporary Framework adopted by the Commission on 19 March 2020, as amended […]
Today, Sudan, the European Union, Germany, and the United Nations co-hosted a virtual High-Level Sudan Partnership Conference. The Joint Communiqué adopted by the participants, confirmed the support of the international community to the democratic and economic transition in Sudan headed by the civilian-led transitional Government. In addition to displaying strong political support to the ongoing […]
The European Union is mobilising €97.2 million of additional funding for programmes in the Horn of Africa to support the creation of job opportunities, public finance management, and access to education for vulnerable groups, in particular refugees and displaced persons, under the European Union Emergency Trust Fund for Africa (EUTF). Commissioner for International Partnerships Jutta […]
The European Commission has approved two Cypriot schemes providing direct grants and subsidised interest rates to companies and self-employed workers affected by the coronavirus outbreak. The schemes were approved under the State aid Temporary Framework adopted by the Commission on 19 March 2020, as amended on 3 April 2020 and 8 May 2020. The first […]
The European Commission has approved a €2.6 million Czech scheme to support companies affected by the coronavirus outbreak. The scheme, set up by the Moravia-Silesia region, was approved under the State aid Temporary Framework adopted by the Commission on 19 March 2020, as amended on 3 April 2020 and 8 May 2020. The public support […]
The European Commission approved two Lithuanian measures, with an estimated total budget of €50 million, to support travel agencies, tour operators, accommodation and catering businesses which were affected by the measures adopted by the Lithuanian authorities to face the coronavirus health emergency. The measures were approved under the State aid Temporary Framework adopted by the […]
This week, an Emergency Medical Team of 10 doctors and nurses from Italy are preparing their mission to Armenia, via the EU Civil Protection Mechanism. They will provide further assistance in addition to last week’s deployed medical experts from Lithuania. In addition, in response to requests for assistance under the Mechanism, Poland has offered disinfectant, […]
On the occasion of the International Day against Drug Abuse and Illicit Trafficking, Vice-President for Promoting our European Way of Life Margaritis Schinas said: “Drug trafficking is still the largest criminal market in the EU; organised crime groups remained active during the pandemic, quickly adapting their drugs operations to the new situation. This comes at […]
• If approved, Xolair® (omalizumab) will provide patients who have severe chronic rhinosinusitis with nasal polyps, not adequately controlled by intranasal corticosteroids, with the first anti-immunoglobulin E (IgE) antibody specifically designed to target and block IgE, a key driver in the inflammatory pathway • Decision based on results from the Phase III POLYP 1 and […]
• EMA CHMP positive opinion paves way for Cosentyx® to become a first-line systemic treatment in pediatric psoriasis • CHMP opinion based on two Phase III studies showing Cosentyx provides fast and strong skin clearance and significant improvement in quality of life1 • Moderate-to-severe psoriasis affects more than 350,000 children worldwide2, with the physical and […]
Novartis has reached settlements with the US Department of Justice (DOJ) and the US Securities and Exchange Commission (SEC) resolving all Foreign Corrupt Practices Act (FCPA) investigations into historical conduct by the Company and its subsidiaries. As part of the settlements, Novartis and certain of its current and former subsidiaries will pay USD 233.9 million […]
The European Commission has approved an investment worth €47 million from the European Regional Development Fund to build and equip an emergency hospital in Cluj, Romania, which will serve the largely rural North West region. This project consists of nearly 850-bed hospital equipped with advanced technology to ensure better quality emergency care and access to […]
The European Commission has approved a €40 million Portuguese scheme to support companies affected by the coronavirus outbreak in the autonomous region of Madeira. The scheme was approved under the State aid Temporary Frameworkadopted by the Commission on 19 March 2020, as amended on 3 April 2020 and on 8 May 2020. The support will […]
The European Commission has approved a €21 million Belgian scheme to support the production of coronavirus-relevant medical products, equipment, technologies and raw materials in the Flemish region. The scheme was approved under the State aid Temporary Framework adopted by the Commission on 19 March 2020, as amended on 3 April 2020 and 8 May 2020. […]
The European Commission has found the modification of a previously approved Hungarian scheme to support the Hungarian economy in the context of the coronavirus outbreak to be in line with EU State aid rules, in particular with the State aid Temporary Framework adopted by the Commission on 19 March 2020, as amended on 3 April […]
The ‘Global Goal: Unite For Our Future’ campaign launched by the Commission and the international advocacy organisation Global Citizen on 28 May will culminate in a global pledging summit and concert on Saturday 27 June. The aim is to mobilise additional funding to develop and deploy coronavirus vaccines, tests and treatments. Access to vaccines everywhere, […]
The Paul-Ehrlich-Institut, Federal Institute for Vaccines and Biomedicines, has authorised another clinical trial of a vaccine against COVID-19 in Germany. The intensive preliminary scientific advice of the medicines developer CureVac, and the prioritisation of the regulatory activities at the Paul-Ehrlich-Institut for vaccines and biomedicines against COVID-19 have made it possible to complete the authorisation procedure […]
Phase III IPATential150 study evaluating ipatasertib in combination with abiraterone and prednisone/prednisolone compared to current standard-of-care (abiraterone and prednisone/prednisolone alone) plus placebo met its co-primary endpoint of radiographic progression free survival (rPFS) in patients with PTEN loss tumours Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the phase III IPATential150 study met its co-primary […]
…. regardless of PD-L1 status, as initial treatment for people with early triple-negative breast cancer • IMpassion031 data will be discussed with health authorities globally, including the US Food and Drug Administration and the European Medicines Agency • Tecentriq is the only approved cancer immunotherapy for the treatment of metastatic triple-negative breast cancer, a very […]
• FDA approval for Cosentyx® is based on the Phase III PREVENT trial, demonstrating efficacy in active non-radiographic axial spondyloarthritis (nr-axSpA), which is part of the axial spondyloarthritis (axSpA) disease spectrum • There are an estimated 2.7M people living with axial spondyloarthritis (axSpA) in the US; however, it remains significantly underdiagnosed1,2 • nr-axSpA approval is […]
Supporting innovative medical technology is key to Team Europe’s response to the Coronavirus pandemic: this is why the European Investment Bank, together with the European Commission, is backing German biopharmaceutical company BioNTech’s COVID-19 vaccine development and manufacturing programme with up to €100 million in debt financing under the Investment Plan for Europe. Find out more […]
English
Arabic
Chinese (Simplified)
Dutch
French
German
Italian
Japanese
Korean
Portuguese
Russian
Spanish